Research in the Division of Dermatology has focused largely on cutaneous malignancy with national recognition for early retinoid therapy work done here.
We work closely with the UA Cancer Center’s Skin Cancer Institute, for which dermatologist Clara Curiel-Lewandroski, MD, PhD, serves as director of the Pigmented Lesion Clinic and Multidisciplinary Cutaneous Oncology Program. Dr. Curiel-Lewandroski's research covers melanoma chemoprevention, early detection of melanoma, cutaneous T cell lymphomas and skin cancer, as well as novel ways in which medical imaging innovations can assist in screenings.
Studies include extended use of non-steroidal anti-inflammatory drugs, particularly aspirin, and their ability to possibly decrease risk of cutaneous melanoma development—which is responsible for 77 percent of skin cancer deaths.
To learn more about other research programs and clinical trials specific to the Skin Cancer Institute or the UA Cancer Center, click here or on one of the links below.
Current Clinical Trials
Clinical trials at the UA College of Medicine - Tucson often involve a research study conducted to evaluate a medical procedure or medical product, such as a drug. Not all University of Arizona studies involve drugs or interventions. Some studies use surveys or evaluate medical records to find new and better ways to help people. Others recruit healthy subjects, or controls, to better evaluate and compare results with those of non-healthy subjects. You can find current clinical trials in specific categories at the links below:
How to Participate
Whether you’re a potential candidate to participate as a patient or subject in the study, you would like to participate as a "healthy volunteer" for the control group or you’re a research or clinical professional interested in collaborating with the research team—simply contact the study coordinator listed for each individual clinical research study above.